RxDoctor Payments DataLook up a doctor →

Mohamad Sonbol, MD

Hematology & Oncology · Scottsdale, AZNPI 1578904173

Payments from drug & device makers

$1,643,952in general payments, 2019–2025

Across 277 payments — averaging $5934.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$555K
  • Bavarian Nordic A/s$298K
  • Amgen$200K
  • AstraZeneca$190K
  • Macrogenics, Inc.$157K
  • Seagen Inc.$112K
  • plus $131K from 9 others
$3,098in research payments, 2019–2025

Across 1 payment — averaging $3097.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$3K

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,643,952 in reported general payments places this provider in the 85th percentile of 261 hematology & oncology providers in Arizona.

See all hematology & oncology providers in Arizona

Medicare billing

Part B allowed, 2024
$3,183,740
Medicare patients
826
Services billed
111,843

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →